Chimeric antigen receptor T-cell (CAR-T) cell therapy in Hungary in paediatric acute lymphoblastic leukaemia (ALL) and adult diffuse large B-cell lymphoma (DLBCL) disorders (Q3911376): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Edited by the materialized bot - inferring region from the coordinates)
(‎Changed label, description and/or aliases in fr: Adding French translations)
label / frlabel / fr
 
Thérapie cellulaire à cellules T des récepteurs de l’antigène chimérique (CAR-T) en Hongrie en cas de leucémie lymphoblastique aiguë chez l’enfant (ALL) et de troubles du lymphome à cellules B diffusant chez l’adulte (DLBCL)

Revision as of 17:40, 7 December 2021

Project Q3911376 in Hungary
Language Label Description Also known as
English
Chimeric antigen receptor T-cell (CAR-T) cell therapy in Hungary in paediatric acute lymphoblastic leukaemia (ALL) and adult diffuse large B-cell lymphoma (DLBCL) disorders
Project Q3911376 in Hungary

    Statements

    0 references
    3,593,115.942 Euro
    0.00276521 Euro
    3 December 2021
    0 references
    1,299,400,748 forint
    0 references
    94.999998 percent
    0 references
    1 February 2021
    0 references
    1 February 2023
    0 references
    DÉL-PESTI CENTRUMKÓRHÁZ-ORSZÁGOS HEMATOLÓGIAI ÉS INFEKTOLÓGIAI INTÉZET
    0 references
    0 references

    47°29'30.62"N, 18°58'44.15"E
    0 references
    Budapest, Budapest
    0 references

    Identifiers

    EFOP-5.2.6-20-2020-00010
    0 references